Previous Article | Next Article ![]()
J. Virol., 03 1997, 1808-1813, Vol 71, No. 3
Y Tang, AW Hugin, NA Giese, L Gabriele, SK Chattopadhyay, TN Fredrickson, D Kagi, JW Hartley and HC Morse 3rd
CD8+ T cells were previously shown to be important in preventing
lymphoproliferation and immunodeficiency following infection of murine AIDS
(MAIDS)-resistant mice with the LP-BM5 mixture of murine leukemia viruses.
To further evaluate the mechanisms contributing to MAIDS resistance, we
studied mice lacking CD8+ T cells or deficient in perforin due to knockout
of the beta2-microglobulin (beta2M) or perforin gene, respectively. In
contrast to wild-type, MAIDS-resistant controls, B10.A mice homozygous for
the beta2M mutation and B10.D2 mice homozygous for the perforin mutation
were diagnosed as having MAIDS by 5 to 8 weeks after infection by the
criteria of lymphoproliferation, impaired proliferative responses to
mitogens, and changes in cell populations as judged by histopathology and
flow cytometry. Unexpectedly, there was no progression of
lymphoproliferation through 24 weeks, even though immune functions were
severely compromised. Expression of the defective virus responsible for
MAIDS was enhanced in spleens of the knockouts in comparison with wild-type
mice. These results demonstrate that perforin-dependent functions of CD8+ T
cells contribute to MAIDS resistance but that other, non-CD8-dependent
mechanisms are of equal or greater importance.
Copyright © 1997, American Society for Microbiology
Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8+ T cells or perforin
Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|